FENTANYL
Manufacturer: ALVOGEN
Score: 144.0
Fentanyl transdermal system is used for the management of severe and persistent pain that requires an extended treatment with a daily opioid analgesic and for which alternative treatment options are inadequate. The system is contraindicated in patients who are not opioid-tolerant, and its use is associated with serious risks, including addiction, abuse, and misuse, life-threatening respiratory depression, and neonatal opioid withdrawal syndrome. The recommended dosage is individualized and based on the patient's previous opioid usage, with careful titration to minimize adverse effects.
Addiction, abuse, and misuse; life-threatening respiratory depression; neonatal opioid withdrawal syndrome
Titrate carefully to minimize adverse effects, with dose increments no more frequently than 3 days
Individualized based on previous opioid usage
Not recommended for pediatric patients under 2 years of age
FENTANYL TRANSDERMAL
SpecGx LLC
BUPRENORPHINE
Bryant Ranch Prepack
BUPRENORPHINE
INGENUS PHARMACEUTICALS, LLC
BUPRENORPHINE
RedPharm Drug, Inc.
BUPRENORPHINE
Amneal Pharmaceuticals NY LLC
BUPRENORPHINE
Bryant Ranch Prepack
BUPRENORPHINE
Bryant Ranch Prepack
BUPRENORPHINE
AvPAK
BUPRENORPHINE
Teva Pharmaceuticals USA, Inc.
BUPRENORPHINE
Braeburn Inc.
BUPRENORPHINE
Bryant Ranch Prepack
BUPRENORPHINE
Indivior Inc.
BUPRENORPHINE
American Health Packaging
BUPRENORPHINE
Redpharm drug
BUPRENORPHINE
Actavis Pharma, Inc.
BUPRENORPHINE
Rhodes Pharmaceuticals L.P.
BUPRENORPHINE
NuCare Pharmaceuticals,Inc.
BUPRENORPHINE
Clinical Solutions Wholesale, LLC
BUPRENORPHINE
Sun Pharmaceutical Industries, Inc.
BUPRENORPHINE
Rhodes Pharmaceuticals L.P.
METHADONE HYDROCHLORIDE
Hikma Pharmaceuticals USA Inc.
OXYCODONE HYDROCHLORIDE
Bryant Ranch Prepack
PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
Actavis Pharma, Inc.